Erektile dysfunktion. Eine wichtige manifestation der autonomen diabetischen neuropathie

Translated title of the contribution: Erectile dysfunction. A major manifestation of autonomic diabetic neuropathy
  • Max Josef Hilz

Research output: Contribution to journalShort surveypeer-review

3 Scopus citations

Abstract

In Germany, some 4-6 million men, including 1.2 million diabetics, suffer from erectile dysfunction (ED). Various other diseases including heart disease, hypertension, arteriosclerosis, hypedipidemia, endocrine disorders, chronic renal insufficiency, prior radical prostatectomy, neurological diseases, trauma and the abuse of alcohol, tobacco, and side effects of medications, are frequently associated with ED. Medical history, clinical examination, routine blood chemistry and sexual hormone levels may help clarify the etiology of ED. Normally, relaxation of the smooth muscles of the corpus cavernosum - mediated by cGMP and cAMP- together with dilatation of penile arteries and occlusion of venous outflow, results in an erection. The oral type V phosphodiesterase inhibitor, Sildenafil, or prostaglandin E1 injection elevates the cGMP and cAMP levels, respectively. Other therapeutic options include mechanical aids, surgery, hormone replacement or sublingual apomorphine. Since 1998, Sildenafil, an effective, simple and safe oral treatment, has been available.

Translated title of the contributionErectile dysfunction. A major manifestation of autonomic diabetic neuropathy
Original languageGerman
Pages (from-to)41-44
Number of pages4
JournalMMW Fortschritte der Medizin
Volume144
Issue number47
StatePublished - 21 Nov 2002
Externally publishedYes

Keywords

  • 5-phosphodiesterase inhibitors
  • Diagnosis
  • Erectile dysfunction
  • Physiological mechanisms
  • Treatment options

Fingerprint

Dive into the research topics of 'Erectile dysfunction. A major manifestation of autonomic diabetic neuropathy'. Together they form a unique fingerprint.

Cite this